| Dr Daniel Frederick Mcbride, MD, MPH | |
|
102 E Lake Mead Pkwy, Henderson, NV 89015-5575 | |
| (702) 564-2622 | |
| Not Available |
| Full Name | Dr Daniel Frederick Mcbride |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 20 Years |
| Location | 102 E Lake Mead Pkwy, Henderson, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629049945 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 12380 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sunrise Hospital And Medical Center | Las vegas, NV | Hospital |
| Southern Hills Hospital And Medical Center | Las vegas, NV | Hospital |
| Henderson Hospital | Henderson, NV | Hospital |
| Mountainview Hospital | Las vegas, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shadow Emergency Physicians Pllc | 2860667375 | 94 |
| Fremont Emergency Services Scherr Ltd | 4880684554 | 93 |
News Archive
Roche Canada announced today that Health Canada has approved AVASTIN(R) (bevacizumab), as a single agent, for the treatment of patients with glioblastoma multiforme, the most aggressive primary malignant brain tumour, after relapse or disease progression, following prior therapy.
Almost 6,000 new cases of acute lymphoblastic leukemia, or ALL, are expected to be diagnosed this year in the United States. The blood cancer can affect both children and adults.
Have you ever tried to recall something just before going to sleep and then wake up with the memory fresh in your mind? While we absorb so much information during the day consciously or unconsciously, it is during shut eye that a lot of facts are dispatched to be filed away or fall into oblivion.
Æterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS) ("the Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced the completion of a Phase 1 study of its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer.
› Verified 9 days ago
| Entity Name | Fremont Emergency Services Scherr Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679550149 PECOS PAC ID: 4880684554 Enrollment ID: O20040514000465 |
News Archive
Roche Canada announced today that Health Canada has approved AVASTIN(R) (bevacizumab), as a single agent, for the treatment of patients with glioblastoma multiforme, the most aggressive primary malignant brain tumour, after relapse or disease progression, following prior therapy.
Almost 6,000 new cases of acute lymphoblastic leukemia, or ALL, are expected to be diagnosed this year in the United States. The blood cancer can affect both children and adults.
Have you ever tried to recall something just before going to sleep and then wake up with the memory fresh in your mind? While we absorb so much information during the day consciously or unconsciously, it is during shut eye that a lot of facts are dispatched to be filed away or fall into oblivion.
Æterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS) ("the Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced the completion of a Phase 1 study of its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer.
› Verified 9 days ago
| Entity Name | Shadow Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184795874 PECOS PAC ID: 2860667375 Enrollment ID: O20111212000888 |
News Archive
Roche Canada announced today that Health Canada has approved AVASTIN(R) (bevacizumab), as a single agent, for the treatment of patients with glioblastoma multiforme, the most aggressive primary malignant brain tumour, after relapse or disease progression, following prior therapy.
Almost 6,000 new cases of acute lymphoblastic leukemia, or ALL, are expected to be diagnosed this year in the United States. The blood cancer can affect both children and adults.
Have you ever tried to recall something just before going to sleep and then wake up with the memory fresh in your mind? While we absorb so much information during the day consciously or unconsciously, it is during shut eye that a lot of facts are dispatched to be filed away or fall into oblivion.
Æterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS) ("the Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced the completion of a Phase 1 study of its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer.
› Verified 9 days ago
| Entity Name | Clark Schillinger Emergency Group, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912495151 PECOS PAC ID: 8729343462 Enrollment ID: O20180529002939 |
News Archive
Roche Canada announced today that Health Canada has approved AVASTIN(R) (bevacizumab), as a single agent, for the treatment of patients with glioblastoma multiforme, the most aggressive primary malignant brain tumour, after relapse or disease progression, following prior therapy.
Almost 6,000 new cases of acute lymphoblastic leukemia, or ALL, are expected to be diagnosed this year in the United States. The blood cancer can affect both children and adults.
Have you ever tried to recall something just before going to sleep and then wake up with the memory fresh in your mind? While we absorb so much information during the day consciously or unconsciously, it is during shut eye that a lot of facts are dispatched to be filed away or fall into oblivion.
Æterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS) ("the Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced the completion of a Phase 1 study of its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer.
› Verified 9 days ago
| Entity Name | App Of Nevada Ed Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144872870 PECOS PAC ID: 7911238936 Enrollment ID: O20191004003083 |
News Archive
Roche Canada announced today that Health Canada has approved AVASTIN(R) (bevacizumab), as a single agent, for the treatment of patients with glioblastoma multiforme, the most aggressive primary malignant brain tumour, after relapse or disease progression, following prior therapy.
Almost 6,000 new cases of acute lymphoblastic leukemia, or ALL, are expected to be diagnosed this year in the United States. The blood cancer can affect both children and adults.
Have you ever tried to recall something just before going to sleep and then wake up with the memory fresh in your mind? While we absorb so much information during the day consciously or unconsciously, it is during shut eye that a lot of facts are dispatched to be filed away or fall into oblivion.
Æterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS) ("the Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced the completion of a Phase 1 study of its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Frederick Mcbride, MD, MPH 102 E Lake Mead Pkwy, Henderson, NV 89015-5575 Ph: (702) 564-2622 | Dr Daniel Frederick Mcbride, MD, MPH 102 E Lake Mead Pkwy, Henderson, NV 89015-5575 Ph: (702) 564-2622 |
News Archive
Roche Canada announced today that Health Canada has approved AVASTIN(R) (bevacizumab), as a single agent, for the treatment of patients with glioblastoma multiforme, the most aggressive primary malignant brain tumour, after relapse or disease progression, following prior therapy.
Almost 6,000 new cases of acute lymphoblastic leukemia, or ALL, are expected to be diagnosed this year in the United States. The blood cancer can affect both children and adults.
Have you ever tried to recall something just before going to sleep and then wake up with the memory fresh in your mind? While we absorb so much information during the day consciously or unconsciously, it is during shut eye that a lot of facts are dispatched to be filed away or fall into oblivion.
Æterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS) ("the Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced the completion of a Phase 1 study of its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer.
› Verified 9 days ago
Tim Kuo, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3001 Saint Rose Pkwy, Henderson, NV 89052 Phone: 702-616-6102 | |
Steven Matthew Savage, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1250 American Pacific Dr Apt 1624, Henderson, NV 89074 Phone: 661-609-6431 | |
Dr. Jaime Jessica Primerano, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2380 W Horizon Ridge Pkwy, Suite 110, Henderson, NV 89052 Phone: 702-823-4255 Fax: 702-475-3261 | |
Dr. Julie Ann Rivas, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2380 W Horizon Ridge Pkwy, Suite 110, Henderson, NV 89052 Phone: 702-823-4255 | |
James Hayes, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3001 Saint Rose Pkwy, Henderson, NV 89052 Phone: 330-493-4443 Fax: 330-493-8677 | |
Randall K. Bess, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3001 Saint Rose Pkwy, Henderson, NV 89052 Phone: 702-616-5000 | |
Roger Martinez, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 102 E Lake Mead Pkwy, Henderson, NV 89015 Phone: 330-493-4443 Fax: 330-493-8677 |